Related Experiment Video
Updated: Aug 18, 2026

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease
Published on: October 4, 2021
Pleural effusion and thickening due to cabergoline use in a patient with Parkinson's disease
Sunku H Guptha1, Anthony D Promnitz
1Edith Cavell Hospital, Peterborough PE3 9GZ, UK.
Abstract:
A 62-year-old Caucasian man with a history of Parkinson's disease developed bilateral pleural thickening and a large, right-sided, exudative pleural effusion. Further investigations revealed a chronic inflammatory process involving the pleura as a result of exposure to cabergoline used to treat the Parkinson's disease. The inflammatory process reversed after the discontinuation of cabergoline.
Related Concept Videos
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Parkinson Disease l: Introduction
Parkinson Disease ll: Pathophysiology
Parkinson's Disease: Overview
Pleural Effusion I: Introduction
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's criteria,...
